Nanorobotics has developed a proprietary technology to target and kill cancer cells promptly via the use of Molecular NanoMachines. These tiny machines (size 1 nm) can kill the cell mechanically by drilling and tunneling through the membrane until disrupting its nucleus. We are bringing a new modality to oncology - Mechanotherapy. Our recent animal studies have shown dramatic reduction of melanoma growth that is highly resistant to immunotherapy. And the great news - our Mechanotherapy treatment is decoupled from any cancer pathogenesis, mutational rate, or tumor microenvironment. Our programmable, light-activated, nanorobots open a revolutionary new area in nanomedicine. https://nanorobotics.tech
| Website | https://nanorobotics.tech |
| Employees | 2 (2 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
PHP
+12 more
(view full list)
|
| Industry | Biotechnology, Science and Engineering |
| Keywords | Nanotechnology, Cancer Treatment, Oncology, Nanomedicine, Cancer Research, Drug Delivery, Medical Nanotechnology, Nanomaterials, Cellular Therapy, Targeted Therapy, Biomedical Engineering, Precision Medicine, Innovative Cancer Therapies, Advanced Medicine |
Looking for a particular Nanorobotics employee's phone or email?
Shlomo Nedvetzki is the CTO of Nanorobotics.
2 people are employed at Nanorobotics.